Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000270304, described as "partner of NOB1 homolog pseudogene," is classified as a **pseudogene**—a genomic DNA sequence similar to a known gene but non-functional; that is, it does not encode a functional protein product. Pseudogenes may arise from duplication or retrotransposition events, and although they can sometimes have regulatory roles at the RNA level, they are not considered therapeutic targets such as receptors, enzymes, or transporters. The true protein-coding human **partner of NOB1 homolog** gene is PNO1 (symbol: PNO1, GeneID: 56902), which encodes an RNA-binding protein involved in ribosomal small subunit biogenesis[6][4]. The pseudogene "partner of NOB1 homolog pseudogene" does not appear to have documented function, aliases, or disease associations and is not a receptor, enzyme, transporter, or otherwise classified molecular target. This entry is therefore best categorized as either a misannotation or as having no direct therapeutic relevance. **Key points:** - **This gene is a pseudogene and not a protein-coding gene or recognized therapeutic target.** - There is a functional homolog, *partner of NOB1 homolog* (PNO1, GeneID: 56902), but that is a different gene[6][4]. - No aliases, interacting drugs, mechanisms of action, biomarkers, safety concerns, or relevant biological/disease roles are associated with this pseudogene. If your interest is in the active gene "partner of NOB1 homolog" (not the pseudogene), that would be PNO1, which is an RNA-binding protein involved in ribosome biogenesis and has aliases such as KHRBP1, RRP20, and RNA-binding protein PNO1[4][6]. However, the **pseudogene itself (ENSG00000270304) is not a target and has no therapeutic or biomarker relevance**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on partner of NOB1 homolog pseudogene (ENSG00000270304).